SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

Form 8.5 (EPT/RI)

19 Jun 2025 11:14

RNS Number : 5952N
Panmure Liberum Limited
19 June 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Liberum Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Pod Point Group Holdings plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Pod Point Group Holdings plc

(d) Date dealing undertaken:

18 Jun 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchase

379,470

0.062537 GBP

0.062537 GBP

1p ordinary

Sales

391

0.06357 GBP

0.06357 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

19/06/2025

Contact name:

Rosie Kinsella

Telephone number:

+44 (0)207 886 2574

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGZGMVGLLGKZM
Date   Source Headline
3rd Apr 20247:00 amRNSChange of Joint Corporate Broker
3rd Apr 20247:00 amRNSNotice of Results
2nd Apr 20249:00 amRNSEstablishment of Technology Committee
12th Mar 20249:00 amRNSChange of Registered Office
29th Feb 20248:33 amRNSTotal Voting Rights
20th Feb 20247:00 amRNSCEO Appointment & Directorate Change
20th Feb 20247:00 amRNSTrading Update
14th Feb 202411:24 amRNSBlock Listing Application
31st Jan 202410:45 amRNSTotal Voting Rights
10th Jan 202410:07 amRNSDirector Declaration
8th Dec 20238:47 amRNSBlock listing Interim Review
20th Nov 20233:13 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update and Capital Markets Day
17th Aug 20232:29 pmRNSNotice of Capital Markets Day
10th Aug 20239:00 amRNSNew Contract Win
31st Jul 20237:00 amRNSHalf-year Report
28th Jul 20239:00 amRNSChange of Auditor
27th Jul 20234:11 pmRNSUpdated 2023 Guidance
6th Jul 20237:00 amRNSDirectorate Change
30th Jun 20239:00 amRNSNew Contract Win
28th Jun 20239:00 amRNSNew Contract Win
14th Jun 202310:10 amRNSResult of AGM
8th Jun 20239:14 amRNSBlock listing Interim Review
31st May 20239:29 amRNSDirector Declaration
25th May 20231:50 pmRNSDirector/PDMR Shareholding
28th Apr 20235:27 pmRNSAnnual Report & Notice of AGM
31st Mar 20233:47 pmRNSDirector/PDMR Shareholding
31st Mar 202310:24 amRNSTotal Voting Rights
21st Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20231:37 pmRNSBlock Listing Application
17th Feb 20237:00 amRNSPreliminary Unaudited Results for FY2022
16th Feb 20239:58 amRNSBoard Committee Change
11th Jan 20237:00 amRNSCompany Secretary Change
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 202210:32 amRNSDirector/PDMR Shareholding
22nd Dec 20224:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSExercise of Options and Issue of Shares
9th Dec 20227:00 amRNSBlock listing Interim Review
5th Dec 20227:00 amRNSCFO Appointment
21st Nov 20227:00 amRNSTrading Statement
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
31st Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSTotal Voting Rights
27th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.